Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Aug 12, 2020 11:20 am EDT

OPKO Health’s GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services

Aug 5, 2020 3:35 pm EDT

OPKO Health to Participate in BTIG Virtual Biotechnology Conference

Jul 30, 2020 4:05 pm EDT

OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results

Jul 27, 2020 8:00 am EDT

OPKO Health to Report Second Quarter 2020 Financial Results on July 30, 2020

Jul 20, 2020 2:45 pm EDT

OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)

Jul 13, 2020 8:00 am EDT

OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees

Jul 9, 2020 8:00 am EDT

Major League Soccer Chooses OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for Players and Employees

Jul 1, 2020 8:15 am EDT

OPKO Health's BioReference Laboratories Reports Results of COVID-19 Testing for Almost One Quarter of a Million Nursing Home and Live-in Facility Employees

Jun 9, 2020 8:00 am EDT

OPKO Health Announces Positive Top-Line Results of Phase 3 Efficacy and Safety Study of Somatrogon for the Treatment of Japanese Children with Growth Hormone Deficiency

Jun 1, 2020 8:00 am EDT

FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients